New Orleans, LA - Saturday 6/8/19

| Article

| Article

Effective pain management has been deemed a human right, but some chronic pain patients perceive that to mean they are entitled to opioid analgesics for prolonged pain control. In response to these expectations, providers may feel pressured to say “Yes” and continue prescribing opioids, thereby...

| Article

There is much controversy around many aspects of pain treatment, and compelling arguments have focused on both sides of the fence regarding appropriate opioid use and prescribing, legalization of marijuana, and the safety of cox-2 inhibitors. In all  3 cases, there are issues associated with strong...

| Article

| Article

This presentation will offer attendees insight into the burden experienced by people suffering from migraine headaches. We will examine new advances in both our understanding of migraines and the pathophysiology of migraines that may lead to new treatments.

| Article

Lunch will be served.

Sponsored by SCILEX.

| Article

| Article

| Article

When tapering opioid therapy, frontline practitioners may at times be faced with chronic pain patients suffering from undiagnosed mental health disorders. In most cultures, the majority of mental health cases go unrecognized in primary care settings. About 60% of previously undetected cases could...

| Article

The gabapentinoids are a popular class of medications among prescribers for use in chronic pain and various other neurological conditions. In fact, prescription rates for both gabapentin and pregabalin have increased in the United States and other countries in recent years. However, these...

Subscribe to New Orleans, LA - Saturday 6/8/19

Sign Up

Subscribe to the PAINWeek Newsletter
and get our latest articles and more directly in your inbox.